BVF Inc’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BVF Inc’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,216,403	Closed	-$2.01M	–	49
2017 Q4	$2.01M	Buy	1,216,403 +209,896	+21%	+$361K	0.24%	40
2017 Q3	$1.45M	Hold	1,006,507	–	–	0.18%	36
2017 Q2	$1.63M	Sell	1,006,507 -2	-0%	-$4	0.25%	32
2017 Q1	$3.43M	Buy	1,006,509 +998,722	+12,826%	+$4.72M	0.58%	27
2016 Q4	$40K	Buy	+7,787	New	+$135K	0.01%	29
2015 Q1	–	Sell	-69,953	Closed	-$884K	–	31
2014 Q4	$884K	Hold	69,953	–	–	0.17%	30
2014 Q3	$1.07M	Hold	69,953	–	–	0.22%	29
2014 Q2	$1.9M	Hold	69,953	–	–	0.3%	21
2014 Q1	$1.88M	Hold	69,953	–	–	0.29%	22
2013 Q4	$17K	Hold	69,953	–	–	﹤0.01%	26
2013 Q3	$2.25M	Hold	69,953	–	–	0.39%	23
2013 Q2	$2.07M	Buy	+69,953	New	+$2.61M	0.4%	21

Other funds holding ANTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BVF Inc's ANTH Position: Q1 2018 in Review

BVF Inc sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 1,216,403 shares — an estimated $2.01M sold.

BVF Inc first reported a position in ANTH in Q2 2013 and held it in 12 quarters. The position peaked at $3.43M in Q1 2017. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

BVF Inc reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
BVF Inc sold 1,216,403 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2.01M.
BVF Inc first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
BVF Inc's Anthera Pharmaceuticals, Inc. position peaked at $3.43M in Q1 2017.
28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on BVF Inc's 13F filing for Q1 2018, filed 7 May 2018.